Profit excluding FX impact and Extra item /3 Deferred revenue from assets monetization to WHABT in 2015 which recognized in the first quarter of 2019 as a result of accounting standard adjustment (TFRS 15
subsidiary Aphakorn Industries Company Limited change status from an associate to a subsidiary which receive repayment from PA Capital Company Limited is making a profit from fair value adjustment of 6.14
compensation for distribution of the Company’s products through independent pharmacies, totaling approximately Baht 22.63 million which mounted year-on-year by Baht 19 .4 4 million ( the employment of Zuellig
products through independent pharmacies, totaling approximately Baht 22.63 million which mounted year-on-year by Baht 19 .4 4 million ( the employment of Zuellig Pharma Ltd. took effect as from September 1
independent pharmacy channel, totaling approximately 4.99 million baht which increased by 2.24 million baht year-on-year due to increased sales. Some expenses have dropped i. e. sales promotion expenses, booth
and services 135.1 86.4% 53.7 32.5% -81.4 -60.3% Gross Profit 21.2 13.6% 111.5 67.5% 90.3 426.0% Loss from fair vale adjustment for investment properties - - -55.0 33.3% -55.0 100.0% Other Income 22.0
been audited by the independent auditor as follows: Statements of Comprehensive Income for the 4th Quarter and Year Ended December 31, 2018 Note: During 1Q’17, the subsidiary has recorded income incurred
Baht from capital adjustment by purchase price allocation method (PPA) proposed by independent assessor. Legacy Asia Capital Pte. Ltd., (“Legacy”) whose 70% of total shares were previously held by NCL
Company Limited (“the Company”) would like to clarify the operating results of the Company and its subsidiary for the 2nd quarter ended June 30, 2019 which has been audited by the independent auditor as